Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer

Farhoud Faraji1,2,3, Sydney I Ramirez3,4, Paola Y Anguiano Quiroz5

  • 1Department of Otolaryngology-Head and Neck Surgery, University of California San Diego Health, La Jolla, CA 92093, USA.

Cells
|April 23, 2022
PubMed

Insights

Head and neck squamous cell carcinoma (HNSCC) is a deadly cancer. Hippo pathway alterations, including FAT1, WWTR1, and YAP1 gene changes, drive HNSCC development and offer new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Head and neck squamous cell carcinoma (HNSCC) remains a prevalent and lethal malignancy with limited therapeutic advancements.
  • Despite progress in surgery, radiation, and targeted treatments, prognosis for advanced HNSCC has stagnated, with poor response rates to immune checkpoint inhibitors.

Purpose of the Study:

  • To investigate the role of the Hippo signaling pathway in HNSCC development.
  • To identify specific genetic alterations within the Hippo pathway that contribute to HNSCC oncogenesis.
  • To explore potential therapeutic strategies targeting Hippo pathway vulnerabilities in HNSCC.

Main Methods:

  • Analysis of the human HNSCC oncogenome to identify genetic alterations.
  • Examination of mutations, deletions, and amplifications in key Hippo pathway genes (FAT1, WWTR1, YAP1).
  • Review of existing literature on Hippo pathway function and its role in cancer.

Main Results:

  • Genomic alterations impairing Hippo signaling and activating YAP/TAZ were identified in HNSCC.
  • FAT1 gene alterations (mutations/deletions) occurred in 29% of cases.
  • WWTR1 (TAZ) and YAP1 gene amplifications were observed in 14% and 8% of cases, respectively.

Conclusions:

  • Aberrant Hippo signaling, driven by genetic alterations in FAT1, WWTR1, and YAP1, is a significant oncogenic mechanism in HNSCC.
  • These findings highlight the Hippo pathway as a critical player in HNSCC initiation and progression.
  • Targeting Hippo pathway vulnerabilities presents a promising avenue for developing novel precision therapies for HNSCC.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K